207 related articles for article (PubMed ID: 32318342)
21. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
Rossini M; Rizzo P; Bononi I; Clementz A; Ferrari R; Martini F; Tognon MG
Front Oncol; 2018; 8():91. PubMed ID: 29666782
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
Demir M; Kaya H; Taylan M; Ekinci A; Yılmaz S; Teke F; Sezgi C; Tanrikulu AC; Meteroglu F; Senyigit A
Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653
[TBL] [Abstract][Full Text] [Related]
23. [microRNAs as biological indicators of environmental and occupational exposure to asbestos].
Minoia C; Sturchio E; Porro B; Ficociello B; Zambelli A; Imbriani M
G Ital Med Lav Ergon; 2011; 33(4):420-34. PubMed ID: 22452101
[TBL] [Abstract][Full Text] [Related]
24. Methylation profile landscape in mesothelioma: possible implications in early detection, disease progression, and therapeutic options.
Zhang X; Tang N; Rishi AK; Pass HI; Wali A
Methods Mol Biol; 2015; 1238():235-47. PubMed ID: 25421663
[TBL] [Abstract][Full Text] [Related]
25. A narrative review of the health disparities associated with malignant pleural mesothelioma.
Freudenberger DC; Shah RD
J Thorac Dis; 2021 Jun; 13(6):3809-3815. PubMed ID: 34277071
[TBL] [Abstract][Full Text] [Related]
26. Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Gayosso-Gómez LV; Zárraga-Granados G; Paredes-Garcia P; Falfán-Valencia R; Vazquez-Manríquez ME; Martinez-Barrera LM; Castillo-Gonzalez P; Rumbo-Nava U; Guevara-Gutierrez R; Rivera-Bravo B; Ramirez-Venegas A; Sansores R; Negrete-Garcia MC; Ortiz-Quintero B
EXCLI J; 2014; 13():740-50. PubMed ID: 26417297
[TBL] [Abstract][Full Text] [Related]
27. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma.
Schiavello M; Gazzano E; Bergandi L; Silvagno F; Libener R; Riganti C; Aldieri E
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33799965
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
29. [Exploratory study on the detection of markers for diagnosing early-stage malignant mesothelioma].
Fukuoka K; Tanaka F; Tsujimura T; Hashimoto-Tamaoki T; Hasegawa S; Nakano T
Nihon Eiseigaku Zasshi; 2011 May; 66(3):553-7. PubMed ID: 21701086
[TBL] [Abstract][Full Text] [Related]
30. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction.
Gandhi M; Nair S
Life Sci; 2020 Sep; 257():118123. PubMed ID: 32710945
[TBL] [Abstract][Full Text] [Related]
31. Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study.
Casalone E; Birolo G; Pardini B; Allione A; Russo A; Catalano C; Mencoboni M; Ferrante D; Magnani C; Sculco M; Dianzani I; Grosso F; Mirabelli D; Filiberti RA; Rena O; Sacerdote C; Rodriguez-Barranco M; Smith-Byrne K; Panico S; Agnoli C; Johnson T; Kaaks R; Tumino R; Huerta JM; Riboli E; Heath AK; Trobajo-Sanmartín C; Schulze MB; Saieva C; Amiano P; Agudo A; Weiderpass E; Vineis P; Matullo G
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612122
[TBL] [Abstract][Full Text] [Related]
32. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
[TBL] [Abstract][Full Text] [Related]
34. Pleural Mesothelioma with No Asbestos Exposure: A Case Report.
Batahar SA; Ouradi O; Elidrissi S; Amro L
J Clin Diagn Res; 2016 Nov; 10(11):OD07-OD08. PubMed ID: 28050426
[TBL] [Abstract][Full Text] [Related]
35. Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.
Kirschner MB; Pulford E; Hoda MA; Rozsas A; Griggs K; Cheng YY; Edelman JJ; Kao SC; Hyland R; Dong Y; László V; Klikovits T; Vallely MP; Grusch M; Hegedus B; Dome B; Klepetko W; van Zandwijk N; Klebe S; Reid G
Br J Cancer; 2015 Sep; 113(6):963-9. PubMed ID: 26263483
[TBL] [Abstract][Full Text] [Related]
36. An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective.
Emami H; Ilbeigi A; Khodadad K
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2619-2623. PubMed ID: 29072053
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of malignant pleural mesothelioma.
Jaurand MC; Fleury-Feith J
Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
[TBL] [Abstract][Full Text] [Related]
38. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
Rodríguez Portal JA; Rodríguez Becerra E; Rodríguez Rodríguez D; Alfageme Michavila I; Quero Martínez A; Diego Roza C; León Jiménez A; Isidro Montes I; Cebollero Rivas P
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):646-50. PubMed ID: 19190155
[TBL] [Abstract][Full Text] [Related]
40. Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma.
Abd-Elmawla MA; Abdel Mageed SS; Al-Noshokaty TM; Elballal MS; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Midan HM; Rizk NI; Elrebehy MA; Sayed GA; Tabaa MME; Salman A; Mohammed OA; Ashraf A; Khidr EG; Khaled R; El-Dakroury WA; Helal GK; Moustafa YM; Doghish AS
Pathol Res Pract; 2023 Oct; 250():154817. PubMed ID: 37713736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
